Birchview Capital, LP - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 143 filers reported holding KARYOPHARM THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.4%.

Quarter-by-quarter ownership
Birchview Capital, LP ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$766,255
+46.9%
571,832
+96.3%
0.65%
+66.8%
Q2 2023$521,484
+45926.8%
291,3320.0%0.39%
-55.9%
Q1 2023$1,133
+14.3%
291,3320.0%0.89%
+26.7%
Q4 2022$991
-99.9%
291,332
+8.2%
0.70%
-32.4%
Q3 2022$1,471,000
+21.1%
269,3320.0%1.04%
+17.2%
Q2 2022$1,215,000
-38.8%
269,3320.0%0.88%
-38.1%
Q1 2022$1,985,000
+25.5%
269,332
+9.5%
1.43%
+40.1%
Q4 2021$1,582,000
+10.5%
246,0000.0%1.02%
+4.7%
Q3 2021$1,432,000
-39.7%
246,000
+7.0%
0.97%
-31.4%
Q2 2021$2,374,000
-1.9%
230,0000.0%1.42%
-1.2%
Q1 2021$2,420,000
-16.8%
230,000
+22.3%
1.44%
-14.3%
Q4 2020$2,910,000
-40.7%
188,000
-44.0%
1.68%
+2.3%
Q3 2020$4,906,000
+54.2%
336,000
+100.0%
1.64%
-14.8%
Q2 2020$3,182,000
+11.9%
168,000
+13.5%
1.92%
-23.8%
Q1 2020$2,843,000
+85.3%
148,000
+85.0%
2.52%
+126.2%
Q4 2019$1,534,000
+127.9%
80,000
+14.3%
1.12%
+148.9%
Q3 2019$673,000
+60.6%
70,0000.0%0.45%
+75.7%
Q2 2019$419,000
+2.4%
70,0000.0%0.26%
-0.4%
Q1 2019$409,000
-37.7%
70,0000.0%0.26%
-58.8%
Q4 2018$656,000
-23.0%
70,000
+40.0%
0.62%
+12.9%
Q3 2018$852,000
+0.2%
50,0000.0%0.55%
-4.8%
Q2 2018$850,00050,0000.58%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders